Navigation Links
Reaction Monitoring of Processes Under Pressure Using In Situ FTIR
Date:1/19/2009

Compliementary webinar explains the value of in situ mid IR reaction monitoring for promoting a detailed understanding of catalytic and other chemical reactions under pressure.

Columbia, MD (PRWEB) January 19, 2009 -- METTLER TOLEDO invites you to attend a complimentary webinar presented by Dr.Will Kowalchyk Reaction Monitoring of Processes Under Pressure Using In Situ FTIR taking place on April 1, 2009.

Monitoring reactions under pressure poses many challenges. Often, it is impossible to see into the reactor or process because the required pressure necessitates using a metal reactor instead of glass. It is difficult to know when the reaction is complete, much less being able to characterize the reaction kinetics. The accumulation of an unwanted or hazardous species is not uncommon. Taking samples for offline analysis (i.e. HPLC, GC, NMR) can introduce air or moisture into the reaction which can poison catalyst or the samples simply do not reflect the concentrations of the reactive species in their natural environment.

ReactIR™ real-time in situ FTIR can provide a "molecular movie" of the chemical reaction under actual process conditions, including under high pressure. The functional group specificity of FTIR allows the simultaneous monitoring of many chemical species. Our range of probe technologies, specifically designed for pressure chemistry, allows reactions to be monitored to over 350 bar.

This webinar will outline the relevant probe designs and technology for monitoring reactions at elevated pressure. Several pressure chemistry case studies will be presented including reductions (hydrogenation), oxidations, carbonylations, hydroformylations and reactions in supercritical CO2. Schematics and pictures of actual installations will be reviewed showing some very common ways to interface our Comp™ probe technology into a process.

###

Read the full story at http://www.prweb.com/releases/catalytic/reactions/prweb1876654.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests
2. DNA Predicts Reaction to Drug That Fights Alcohol Dependence
3. Baxter Provides Update on Heparin Reactions
4. Informex365.com is Launched for Manufacturers in Search of Chemical Reactions Expertise
5. GM Exec Joins Bio-Reaction Industries Board of Directors
6. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
7. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
8. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
9. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
10. Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting
11. Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Reaction Monitoring of Processes Under Pressure Using In Situ FTIR
(Date:12/7/2016)... 7, 2016  Nordion, a standalone business of ... welcome today,s award by the United States Department ... of the Phase II cooperative agreement funding to ... the University of Missouri Research Reactor Center (MURR ... the establishment of a new, reliable supply of ...
(Date:12/7/2016)... ROCHESTER, Minn. , Dec. 7, 2016  Vyriad ... McQuinn to the company,s Board of Directors. ... board as we build our business and develop our ... for cancer therapy," said Stephen Russell , MD, ... Mary Agnes , share our vision and passion for ...
(Date:12/7/2016)... and ANN ARBOR, Mich. , ... biopharmaceutical company developing breakthrough immune modulatory medicines, announced today ... the Company,s lead therapeutic candidate, LYC-30937- E nteric ... a debilitating skin disease that is estimated to affect ... United States , with approximately 1.5 - 3 ...
(Date:12/7/2016)... ... 2016 , ... Proscia Inc., the provider of the leading ... migration of large pathology data sets to the Proscia Pathology Cloud platform. The ... digital pathology. Proscia’s free massive dataset migrator makes the secure, HIPAA-compliant upload of ...
Breaking Biology Technology:
(Date:11/28/2016)... "The biometric system market projected to ... system market is in the growth stage and is ... biometric system market is expected to be valued at ... 16.79% between 2016 and 2022. Government initiative in adoption ... rising use of biometric technology in financial institutes and ...
(Date:11/22/2016)... MINNETONKA, Minn. , Nov. 22, 2016   ... that supports the entire spectrum of clinical research, is ... by Medical LiveWire Healthcare and Life Sciences Awards ... This award caps off an unprecedented year of recognition ... clinical trials for over 15 years. iMedNet ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to ... for Private Biobanks shows the highest Compounded Annual Growth Rate ... region during the analysis period 2014-2020. North ... of 9.95% followed by Europe at ...
Breaking Biology News(10 mins):